Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
RPTP > SEC Filings for RPTP > Form 8-K on 24-May-2013All Recent SEC Filings

Show all filings for RAPTOR PHARMACEUTICAL CORP | Request a Trial to NEW EDGAR Online Pro



Creation of a Direct Financial Obligation or an Obligation under an Of

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

On May 21, 2013, Raptor Pharmaceutical Corp., a Delaware corporation (the "Company"), drew an aggregate of $25.0 million pursuant to the second tranche of its loan agreement (the "Loan Agreement") with HealthCare Royalty Partners II, L.P. ("HealthCare Royalty Partners"), dated December 20, 2012, which resulted in net proceeds to the Company of approximately $23.7 million. Pursuant to the terms of the Loan Agreement, the Company agreed to borrow an aggregate of $50.0 million in aggregate principal in two $25.0 million tranches. The first tranche was received in connection with the entry into the Loan Agreement. The receipt of the second tranche was triggered upon U.S. Food and Drug Administration approval of PROCYSBI™ for the potential treatment of nephropathic cystinosis in adults and children six (6) years and older, which the Company received on April 30, 2013.
For additional information regarding the Company's Loan Agreement with HealthCare Royalty Partners, see Item 1.01 and Item 2.03 of the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on December 26, 2012, which information is incorporated by reference herein.

  Add RPTP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for RPTP - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.